Aim ImmunotechAIM

13F holders, Q3 2025 (September 30)
15holders +3
5new positions
3sold out
$2.74avg. 13F price*

At the end of Q3 2025, 15 institutions reported holding Aim Immunotech Inc. (AIM) in their 13F filings, up 3 from Q2 2025. 5 opened new positions and 3 sold out. The largest holders were DRW Securities, LLC ($119K), Sabby Management, LLC ($79K) and Vanguard Group Inc. ($48K).

Company
Aim Immunotech Inc.
CUSIP
00901B303
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q2 2025: 12Q2 2025Q3 2025: 15Q3 2025Q4 2025: 13Q4 2025Q1 2026: 18Q1 2026Q2 2026: 18Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions5$290K
Exits3$87K

All 13F filers, Q2 2025 → Q3 2025: 106,012 shares bought and 10,881 shares sold, net +95,131 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

DRW Securities, LLC 0.01% New 43,291 $119K
Sabby Management, LLC 0.41% New 28,855 $79K
Vanguard Group Inc. 0.00% New 17,502 $48K
Geode Capital Management, LLC 0.00% New 16,186 $44K
Morgan Stanley 0.00% Add +13.3% 863 $2K
UBS Group AG 0.00% Reduce -74.3% 304 $833
Community Bank, N.A. 0.00% No change 132 $361
PNC Financial Services Group, Inc. 0.00% New 50 $137
Bank of America Corp. 0.00% Add +440.0% 27 $74
Osaic Holdings, Inc. 0.00% Add +50.0% 15 $37
Hoey Investments, Inc. 0.00% No change 10 $28
Harbour Investments, Inc. 0.00% No change 10 $27
Wells Fargo & Company 0.00% No change 4 $11
Steward Partners Investment Advisory, LLC 0.00% No change 2 $5
Farther Finance Advisors, LLC 0.00% No change 1 $3

"% of holder's portfolio" is AIM's weight in each manager's 13F, not the share of Aim Immunotech Inc. the manager owns.